- Case report
- Open Access
- Open Peer Review
Sarcoid reaction associated with Merkel cell carcinoma revealed by fluorodeoxyglucose positron emission tomography: a case report
© Higashi et al; licensee BioMed Central Ltd. 2011
- Received: 30 September 2010
- Accepted: 5 July 2011
- Published: 5 July 2011
- Sentinel Lymph Node
- Mediastinal Lymph Node
- Merkel Cell Carcinoma
- Small Cell Lung Carcinoma
Although the association between cancer and sarcoidosis or sarcoid reaction is known, sarcoid reaction associated with Merkel cell carcinoma is rare.
We report the case of a 57-year-old Japanese woman with Merkel cell carcinoma in the inguinal area associated with sarcoid reaction. Fluorodeoxyglucose positron emission tomography demonstrated elevated fluorodeoxyglucose uptake by mediastinal lymph nodes and at the carcinoma site. Histopathologically, the mediastinal lymph nodes contained no Merkel cell carcinoma components. Sarcoid lesions were identified. Systemic examinations returned no sarcoidosis-specific findings.
Fluorodeoxyglucose positron emission tomographic scans can be used to assess neoplastic lesions and depict sarcoidosis. Sarcoid reactions must be considered in the interpretation of fluorodeoxyglucose positron emission tomographic scans.
Sarcoidosis, a common systemic disorder of unknown etiology, is characterized by the formation of non-caseating epithelioid cell granulomas. The lungs, lymph nodes, liver, spleen, skin, eyes, small bones of the hands and feet and the salivary glands are most often affected . A diagnosis of sarcoid reaction is made when localized epithelioid granulomas are found without signs of systemic sarcoidosis. They are attributable to infections, foreign materials, gastrointestinal diseases and malignant tumors . The reported incidence of sarcoid reactions in carcinoma is 4.4%; in squamous cell carcinoma of the skin and mucous membranes, it is 13.0% . Merkel cell carcinoma is a rare and aggressive skin cancer that is thought to arise from cutaneous Merkel cells which are neuroendocrine cells . We present the case of a patient with Merkel cell carcinoma associated with sarcoid reaction.
The association of sarcoid reaction with Merkel cell carcinoma is rare. Our literature review uncovered a case of an 84-year-old woman with Merkel cell carcinoma and chronic sarcoidosis . Her carcinoma was diagnosed nine years after sarcoidosis, and ductal breast carcinoma was diagnosed six months before Merkel cell carcinoma. As the pathogenesis of sarcoidosis involves immune dysfunction , her two different malignant tumors may be attributable to disturbances in the immune system, which play an important role in immune surveillance. A longitudinal study adjusted for age, sex and smoking history showed a significantly higher incidence of cancer in patients with sarcoidosis than in the general population . Sarcoidosis can develop after cancer, and in some patients there is an association between the administration of anti-neoplastic drugs and the appearance of sarcoidosis [6–8]. Although our patient manifested sarcoid reaction rather than sarcoidosis, it remains unknown whether sarcoid reaction in the presence of malignancy is different from systemic sarcoidosis involvement in the etiology of cancer.
Merkel cell carcinoma, composed of small, round blue cells, should be distinguished from small cell lung carcinoma, which has a similar pathological appearance. Their differentiation is possible because antibodies to cytokeratin 20 and thyroid transcription factor 1 are specific to Merkel cell carcinoma and small cell lung carcinoma, respectively .
In our patient, the immunohistochemical findings regarding the inguinal mass and the absence of tumor cells in the mediastinal lymph node led to a diagnosis of Merkel cell carcinoma arising in the inguinal region. Her sarcoid reaction was mediastinal. Although sarcoid reactions are most commonly observed in cancer-draining lymph nodes, they can occur in non-regional tissues [2, 6]. They are thought to be attributable to soluble antigenic or granulomagenic factors derived from tumor cells and include antigen-antibody complexes, peptides and modified tumor cells . Our observation that the sarcoid reaction in our patient occurred at distant tissue sites supports the involvement of soluble factors.
FDG-PET, widely used to assess neoplastic lesions, depicts the glucose avidity of tissues. Although FDG-PET images reflect the different utilization of glucose by normal and malignant tissues, they fail to differentiate malignancy from inflammation reliably. Increased glucose uptake has been reported in patients with benign disorders [10, 11], and elevated FDG uptake has been observed in patients with sarcoidosis. Brudin et al.  proposed that FDG-PET images reflect disease activity and the distribution of sarcoidosis. In cancer patients with sarcoidosis [13, 14] or sarcoid reaction , FDG-PET has shown lesions that mimicked lymph node metastases. Kaira et al.  reported that the use of L-[3-18F]-α-methyltyrosine PET (18F-FMT PET) in combination with FDG-PET can distinguish sarcoidosis from malignancy. Sarcoid reaction must be considered in the evaluation of cancer metastasis, and the acquisition of 18F-FMT PET scans is desirable.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Gawkrodger DJ: Sarcoidosis. Rook's Textbook of Dermatology. Edited by: Burns T, Breathnach S, Cox N, Griffiths C. 2004, Cambridge: Wiley-Blackwell, Chapter 58: 2669-2992. 7View ArticleGoogle Scholar
- Brincker H: Sarcoid reactions in malignant tumours. Cancer Treat Rev. 1986, 13: 147-156. 10.1016/0305-7372(86)90002-2.View ArticlePubMedGoogle Scholar
- Mackie RM, Calonje E: Tumours of the skin appendages. Rook's Textbook of Dermatology. Edited by: Burns T, Breathnach S, Cox N, Griffiths C. 2004, Cambridge: Wiley-Blackwell, Chapter 37: 1851-1884. 7View ArticleGoogle Scholar
- McLoone NM, McKenna K, Edgar D, Walsh M, Bingham A: Merkel cell carcinoma in a patient with chronic sarcoidosis. Clin Exp Dermatol. 2005, 30: 580-582. 10.1111/j.1365-2230.2005.01800.x.View ArticlePubMedGoogle Scholar
- Le Jeune I, Gribbin J, West J, Smith C, Cullinan P, Hubbard R: The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med. 2007, 101: 2534-2540. 10.1016/j.rmed.2007.07.012.View ArticlePubMedGoogle Scholar
- Cohen PR, Kurzrock R: Sarcoidosis and malignancy. Clin Dermatol. 2007, 25: 326-333. 10.1016/j.clindermatol.2007.03.010.View ArticlePubMedGoogle Scholar
- Umezu H, Chida M, Inoue T, Araki O, Tamura M, Tatewaki M, Fukushima Y, Honma K: Sarcoidosis development during induction chemotherapy for lung cancer mimicked progressive disease. Gen Thorac Cardiovasc Surg. 2010, 434-437.Google Scholar
- Chida M, Inoue T, Honma K, Murakami K: Sarcoid-like reaction mimics progression of disease after induction chemotherapy for lung cancer. Ann Thorac Surg. 2010, 90: 2031-2033. 10.1016/j.athoracsur.2010.06.014.View ArticlePubMedGoogle Scholar
- Leech SN, Kolar AJ, Barrett PD, Sinclair SA, Leonard N: Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1. J Clin Pathol. 2001, 54: 727-729. 10.1136/jcp.54.9.727.View ArticlePubMedPubMed CentralGoogle Scholar
- Kanekura T, Yonekura K, Yoshii N: Increased glucose uptake by keratoacanthoma detected by positron emission tomography. Clin Exp Dermatol. 2007, 32: 581-582. 10.1111/j.1365-2230.2007.02448.x.View ArticlePubMedGoogle Scholar
- Stegger L, Juergens KU, Kliesch S, Wormanns D, Weckesser M: Unexpected finding of elevated glucose uptake in fibrous dysplasia mimicking malignancy: contradicting metabolism and morphology in combined PET/CT. Eur Radiol. 2007, 17: 1784-1786. 10.1007/s00330-006-0466-0.View ArticlePubMedGoogle Scholar
- Brudin LH, Valind SO, Rhodes CG, Pantin CF, Sweatman M, Jones T, Hughes JM: Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med. 1994, 21: 297-305. 10.1007/BF00947964.View ArticlePubMedGoogle Scholar
- Takanami K, Kaneta T, Yamada T, Kinomura S, Yamada S, Fukuda H, Takahashi S: FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports. Clin Nucl Med. 2008, 33: 258-261. 10.1097/RLU.0b013e3181662fda.View ArticlePubMedGoogle Scholar
- Karapetis CS, Strickland AH, Yip D, van der Walt JD, Harper PG: PET and PLAP in suspected testicular cancer relapse: beware sarcoidosis. Ann Oncol. 2001, 12: 1485-1488. 10.1023/A:1012548312538.View ArticlePubMedGoogle Scholar
- Maeda J, Ohta M, Hirabayashi H, Matsuda H: False positive accumulation in 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer. Jpn J Thorac Cardiovasc Surg. 2005, 53: 196-198. 10.1007/s11748-005-0104-9.View ArticlePubMedGoogle Scholar
- Kaira K, Oriuchi N, Otani Y, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Endo K, Mori M: Diagnostic usefulness of fluorine-18-α-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Chest. 2007, 131: 1019-1027. 10.1378/chest.06-2160.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.